The TGA reports a number of adverse events and other concerns received for unapproved peptide products, which include: severe allergic reactions, requiring doses of adrenaline and hospitalisation systemic inflammatory response syndrome (SIRS) (severe inflammation in the body), requiring hospital management generalised hypersensitivity symptoms such as fullbody intense itching, palpitations, pain and sweating wide ranging body side effects, including insomnia, blurred vision, extreme tiredness, flulike illness, joint pain and skin sensitivity musculoskeletal injuries, including plantar fasciitis and Achilles tendinitis, and poor product quality, including unsealed packaging from an online supplier
10.2147/DDDT.S419361 23 AtiaG
Autoimmune conditions: TB-500's immune-modulating effects might interact unpredictably with autoimmune conditions or immunosuppressive medications
This is a black box warning for the entire GLP-1 class based on thyroid C-cell tumor findings in rodent studies
Well dive into what you need to know about AOD 9604 peptides and hopefully help you determine if this might be a treatment option you want to explore
Retatrutide solo data
